Navigation Links
Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
Date:11/10/2010

Asthma Management Guidelines, the Global Initiative for Asthma (GINA) Report on Global Strategy for Asthma Management and Prevention, the World Anti-Doping Agency and the Australian Asthma Management Handbook.

ARIDOL is the only dry powder bronchial challenge test approved for use in the U.S.

Indication

Mannitol, the active ingredient in ARIDOL, is a sugar alcohol indicated for the assessment of bronchial hyperresponsiveness in patients 6 years of age or older who do not have clinically apparent asthma.  

ARIDOL is not a stand alone test or a screening test for asthma.  Bronchial challenge testing with ARIDOL should be used only as part of a physician's overall assessment of asthma.

Important Safety Information

WARNING: RISK OF SEVERE BRONCHOSPASM

Mannitol, the active ingredient in ARIDOL, acts as a bronchoconstrictor and may cause severe bronchospasm.  Bronchial challenge testing with ARIDOL is for diagnostic purposes only.  Bronchial challenge testing with ARIDOL should only be conducted by trained professionals under the supervision of a physician familiar with all aspects of the bronchial challenge test and the management of acute bronchospasm. Medications (such as short acting inhaled beta-agonist) and equipment to treat severe bronchospasm must be present in the testing area.  If severe bronchospasm occurs it should be treated immediately by administration of a short acting inhaled beta-agonist. Because of the potential for severe bronchoconstriction, bronchial challenge testing with ARIDOL should not be performed in any patient with clinically apparent asthma or very low baseline pulmonary function tests (e.g., FEV1 <1-1.5 liters or <70% of the predicted values).

ARIDOL is contraindicated in patients with known hypersensitivity to mannitol, the active ingredient in ARIDOL, or to the gelatin used to make the capsules.  The product is also c
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmaxis Long-Term Safety Study of Bronchitol Completes
2. Pharmaxis Establishes Named Patient Program for Bronchitol
3. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
4. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
5. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
6. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
7. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
8. FDA Approves Pharmaxis ARIDOLâ„¢ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
9. Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
10. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
11. Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... and NEW YORK , Aug. 1, ... Pershing Square Capital Management, L.P. today responded to the ... AGN ) in California.  The complaint makes ... tender offer rules.  Allergan,s true purpose ... with shareholders, efforts to call a special meeting.  That ...
(Date:8/1/2014)... 1, 2014  VanDeMark Chemical Inc., ... of phosgene and phosgene derivatives in ... has acquired Framochem Kft, a leading European-based manufacturer ... . The purchase unites two ... of the world,s largest, independent manufacturers of products ...
(Date:8/1/2014)... Aspire Technology Partners (Aspire) announced today that it has achieved ... recognizes Aspire for delivering outstanding customer service to customers in ... "Achieving exceptional results for our customers is core to ... CEO of Aspire. "We are pleased Cisco has recognized our ... are proud to be part of the Cisco channel." ...
Breaking Medicine Technology:Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6VanDeMark Chemical Inc. Acquires Framochem 2VanDeMark Chemical Inc. Acquires Framochem 3VanDeMark Chemical Inc. Acquires Framochem 4Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2
(Date:8/1/2014)... News) -- Almost 140 people die every year ... United States. But there are several simple ... injury prevention coordinator at Cincinnati Children,s Hospital Medical ... medical center news release. "As families begin ... important for parents and children to go over ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 As AndroGel ... the country, Ronald E. Johnson, Jr. has been appointed ... AndroGel and other testosterone medications. Since the Fall of ... P.S.C. have worked diligently to investigate and prosecute the ... embolisms, and blood clots as a result of taking ...
(Date:8/1/2014)... UK (PRWEB) August 01, 2014 ... Publications research reports have been added to its ... Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and ... The key pharma industry drivers include, among others, ... of personal hygiene. In 2015, the pharma market ...
(Date:8/1/2014)... Alan Mozes HealthDay Reporter ... country, barbershops serve as a time-honored destination for a good ... whether barbershops might also be the spot to tackle an ... In a novel partnership, the U.S. Centers for Disease ... Health (MSDH), enlisted the help of barbershop staff to both ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... industry have benefited from innovative technologies that have ... resemble a patient's tooth color. Moreover, the burgeoning ... due to age-related tooth ailments. Due to long-term ... many elderly individuals have demanded dental fillings, veneers ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... , WEDNESDAY, April 13 (HealthDay News) -- A ... food, researchers report. It was already known that ghrelin ... the hormone may increase the ability to use smell to ... regulation of metabolism and body weight, said University of Cincinnati ...
... , TUESDAY, April 12 (HealthDay News) -- Many smokers ... cigarettes, such as "mild" and "low tar" brands, are less ... Researchers surveyed more than 8,000 smokers in Australia, Canada, ... about one-fifth of them wrongly believed that "some cigarettes could ...
... 12 (HealthDay News) -- Scientists are rearranging the genetic information ... way to learn more about the genetic causes in people ... of the immune system. Humans and dogs have a ... including lymphoma. In purebred dogs of the same breed, however, ...
... a laboratory model of idiopathic torsion dystonia, a neurological ... postures. But the genetic defect that causes dystonia in ... that showed no symptoms whatsoever. Now, a team ... have figured out why and the finding could lead ...
... HealthDay Reporter , TUESDAY, April 12 (HealthDay News) -- ... taking the arthritis drug Humira developed an immune system reaction ... finding helps to explain why some people get relief from ... made by Abbott Laboratories, while others gain little or no ...
... from heart attacks Angiogenesis, the development of ... wound healing, as well as during disease processes such ... incompletely understood, but could represent novel targets for the ... In this paper, Young-Guen Kwon and colleagues, of Yonsei ...
Cached Medicine News:Health News:Many Smokers Still Deceived by Cigarette Labeling 2Health News:Could Dogs' DNA Give Clues to Human Lymphoma? 2Health News:Feinstein scientists identify abnormal disease pathway in dystonia 2Health News:Clues to Why Rheumatoid Arthritis Drug Humira Fails Some Patients 2Health News:Clues to Why Rheumatoid Arthritis Drug Humira Fails Some Patients 3Health News:JCI online early table of contents: April 11, 2011 2Health News:JCI online early table of contents: April 11, 2011 3Health News:JCI online early table of contents: April 11, 2011 4Health News:JCI online early table of contents: April 11, 2011 5Health News:JCI online early table of contents: April 11, 2011 6Health News:JCI online early table of contents: April 11, 2011 7Health News:JCI online early table of contents: April 11, 2011 8
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: